
### [MONDO:0015130](http://purl.obolibrary.org/obo/MONDO_0015130)
**Label:** acquired chronic primary adrenal insufficiency

**Subclasses:** [MONDO:0009410](http://purl.obolibrary.org/obo/MONDO_0009410) (Addison's disease), 

**Corr. equiv. classes:** [OMIM:103230](http://purl.obolibrary.org/obo/OMIM_103230), [Orphanet:85138](http://www.orpha.net/ORDO/Orphanet_85138), [OMIM:240200](http://purl.obolibrary.org/obo/OMIM_240200), 

**Class expressions from DL-Learner:**

- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100646](http://purl.obolibrary.org/obo/HP_0100646) (Thyroiditis) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100522](http://purl.obolibrary.org/obo/HP_0100522) (Thymoma) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100521](http://purl.obolibrary.org/obo/HP_0100521) (Neoplasm of the thymus) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0031066](http://purl.obolibrary.org/obo/HP_0031066) (Abnormal ovarian physiology) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0011849](http://purl.obolibrary.org/obo/HP_0011849) (Abnormal bone ossification) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 66.67%
- [HP:0008226](http://purl.obolibrary.org/obo/HP_0008226) (Androgen insufficiency) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 66.67%


